Drug Giant Is Fined $1.2 Billion in Risperdal Case

A judge fined Johnson & Johnson and a subsidiary after a jury found that the companies minimized or concealed the dangers associated with Risperdal, an antipsychotic drug.

courtland homes new homes atlanta new homes in bay area